Wall Street says sell Goldman, buy Capital One. Here's where we stand

Stocks closed June and Q2 stronger, with the S&P 500 up ~15% and the Nasdaq up ~21%, led by technology/semiconductors; the S&P 500 tech sector rose ~2% in the session. In financials, Goldman Sachs was downgraded to sell-equivalent by Oppenheimer (valuation limited upside), while Jim Cramer highlighted continued deal momentum including Goldman’s role in Martin Marietta’s $13.5B acquisition, and analysts raised Capital One estimates with COF viewed as ~8x forward earnings and potentially undervalued. Near-term catalysts include Nike’s earnings after the bell, Challenger/ADP jobs data for June, and manufacturing indicators (ISM manufacturing and S&P Global PMI), with oil weakness tied to the U.S.-Iran reopening plan supporting the consumer backdrop.

Analysis

The cleanest read-through is not “banks are expensive,” but that the market is still paying up for operating leverage in the parts of finance with visible activity. That favors GS more than MS over the next 1-3 months because advisory/trading can still monetize deal certainty even if underwriting multiples compress. By contrast, the alternative-asset complex (KKR, BX, ARES) remains a better 6-18 month story if spreads stay orderly: private credit fear has likely left fee-related earnings and deployment optionality under-owned, and a mild rate-cut regime would be a bigger catalyst than sentiment currently discounts.

COF is a slower-burn rerating candidate: the market is pricing the integration like a cost story, when the real upside is lower charge-offs plus cheaper funding if consumer delinquencies keep normalizing. The risk is that the next macro wobble shows up first in card losses, so the thesis needs a clean jobs/ISM backdrop over the next 2-3 data prints; if unemployment and consumer delinquencies tick up together, the multiple stays capped. NKE is the highest-event-risk name here: if the print fails to show margin stabilization, this becomes a dead-money turnaround with downside skew as investors lose patience and factor exposure de-rates.

Contrarian view: the recent rotation out of energy and into tech has created a second-order beneficiary basket in financials and consumer credit, not just semis. The consensus is too focused on “late cycle = short banks,” but if M&A and markets hold another few quarters, the better trade is dispersion: own the firms with real fee torque and short the names where the recovery needs perfect execution. The main falsifier is a sharp macro slowdown or a credit-spread break wider, which would hit COF and the alt managers first and quickly unwind the relative-value setup.

Key Decisions for Investors

• Long GS / short MS for 1-3 months: favor the bank with more direct M&A and trading beta if deal activity remains intact; stop if GS underperforms MS by ~5% on an earnings-guidance reset or if advisory pipeline commentary weakens.
• Initiate a starter long in KKR or BX on weakness for a 6-18 month horizon: private-credit sentiment looks washed out relative to fee-earning power; best entry is after any credit-spread scare, with the thesis invalidated by a sustained widening in high-yield spreads or a fundraising freeze.
• Buy COF on pullbacks ahead of the next macro data cluster: the setup is a rerating from integration plus benign credit; risk/reward improves if payrolls and ISM do not deteriorate materially, but cut/hedge if card charge-offs reaccelerate.
• Avoid chasing NKE into earnings; if already long, consider hedging with a put spread into the release: this is a classic event-driven disappointment setup until margin and guidance visibly inflect.
• If you want a cleaner macro hedge, pair long COF with short a consumer cyclicals basket ETF or weaker retail proxy; if growth rolls over, the pair should underperform, but if the consumer holds, COF’s operating leverage should win.